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The Editorial on the Research Topic 
Fatigue in Multiple Sclerosis
Fatigue in Multiple Sclerosis (MS) is one of the most debilitating symptoms in patients with Multiple 
Sclerosis (pwMS). It interferes significantly with career as well as participation in everyday life 
activities. It is an enormous burden to the pwMS, his/her family and friends. Direct and indirect 
costs are extraordinary, both financial and psychosocial. Ongoing scientific studies struggle to 
understand the pathophysiology of fatigue in the hope of improving options for treatment. The past 
decade has seen much progress with important developments emerging to understand different 
phenomena related to fatigue. Most helpful and essential when discussing fatigue is the distinction 
between subjective sensations and objective changes in performance (1) and between trait and 
state fatigue (2). This Research Topic brings together ten novel and exciting perspectives written by 
leading authorities in this area from around the world from both clinical and scientific perspectives 
to understand the multidimensional nature of fatigue.
The first two chapters propose some new and unique concepts in trying to explain fatigue. 
Dobryakova, Genova, DeLuca, and Wylie summarize various lines of evidence suggesting that dopa-
mine imbalance plays a major role in developing fatigue (Dobryakova et al.). The model builds upon 
an earlier framework for studying fatigue suggested by Chaudhuri and Behan (3, 4), who suspected 
that central fatigue was a “failure of the non-motor functions of the basal ganglia.” The current 
manuscript reviews the structural and functional neuroimaging evidence as well as pharmacological 
studies that suggest the critical role that dopamine plays in fatigue.
Hanken, Eling, and Hildebrandt focus on different aspects in their model (Hanken et al.). They 
suggest that the subjective feeling of fatigue is related to inflammation and increased levels of 
cytokines such as interleukin-1 (IL-1), IL-6, TNF-alpha. These inflammatory substances cause a sick-
ness behavior – described as a highly organized strategy of an organism to cope with the infection. 
These authors refer to the original description of the sickness behavior by Maes et al. (5). From their 
structural imaging study, the authors concluded that structural alterations of the brain related to 
fatigue may be found in the insula, anterior cingulate cortex, and the hypothalamus. These structures 
are related to homeostasis and representation of internal bodily states.
Intuitively one might expect that the cognitive load has a significant impact on fatigue. Interestingly, 
Sandry, Genova, Dobryakova, DeLuca, and Wylie describe that it is not the cognitive load, but rather 
the length of the task (i.e., time on task) that is the major driving force in developing fatigue (Sandry 
et al.). This is intriguing and has practical implications for organizing daily routine and workloads 
in pwMS. They also raise the question, whether a decrease in information processing efficiency is 
the major obstacle or whether working memory is of equal importance, and also discuss whether 
fatigue is domain specific.
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Lukoschek, Sterr, Claros-Salinas, Gütler, and Dettmers compare 
fatigue in a large population of pwMS and stroke patients using 
the vitality index of the SF-36. Normalized vitality scores in pwMS 
and stroke were clearly lower than in healthy controls (Lukoschek 
et al.). Fatigue was higher in pwMS than in stroke patients. Both 
patient groups showed no positive correlation between physical 
functioning and fatigue. Fatigue correlated with the working 
capacity in pwMS, but not in stroke patients. This work shows 
the dramatic impact of fatigue on pwMS.
Sehle, Vieten, Mündermann, and Dettmers elaborated on the 
objective assessment of motor fatigue (Sehle et al.). In a previous 
paper, they demonstrated that the attractor is a sensitive tool to 
describe variation and variability in gait patterns (6). This allowed 
for sensitive discrimination between pwMS with and without 
fatigue (7). Beside its relevance for assessment of motor fatigue 
this tool may serve as a model for the organic component of 
cognitive fatigue as “activity dependent loss of function” [analog 
to “activity dependent conduction block” (8)].
While motor fatigue represents a well-characterized concept 
of organic fatigue, fatigue is clearly multidimensional. Schreiber, 
Lang, Kiltz, and Lang elaborate on personality traits, disease 
coping, anxiety and depression, and their interaction (Schreiber 
et al.). It is not a question of either organic or psychogenic factors 
in describing fatigue, but in most instances, both factors contrib-
ute to the expression of fatigue. The authors suggest that fatigue in 
initial stages of MS might be largely driven by factors associated 
with disease coping, while in later stages inflammatory processes 
and lesions might dominate.
Although sleep disturbances are recognized as a cause of 
secondary fatigue, and although one might intuitively consider 
sleep disturbance as a contributing factor to fatigue, its preva-
lence, nature, and importance in patients suffering from fatigue 
are widely under-represented. Strober summarizes her own data 
and the literature regarding the contribution of sleep disturbance 
to the expression of fatigue (Strober).
The following chapters address pharmacological and non-
pharmacological interventions in pwMS. Disease modifying 
drugs are generally used to reduce relapses and progression. 
Kunkel, Fischer, Faiss, Daehne, Köhler, and Faiss describe the 
effect of Natalizumab on cognition, fatigue. and depression in a 
longitudinal, observational study that spanned a 2-year period 
(Kunkel et al.). They found significant improvements in attention 
and depression after this period.
Penner, Sivertsdotter, Celius, Fuchs, Schreiber, Berkö, and 
Svenningsson raised a similar issue (Penner et  al.). In a previ-
ous study, they described the improvement of total, motor, and 
cognitive fatigue during treatment with Natalizumab and 1-year 
follow-up. In the present chapter, they analyze the relationship 
between fatigue depression and daytime sleepiness. They found a 
close relationship between all three variables without being able 
to establish a causal relationship.
Khan, Amatya, and Galea completed the collection with 
a clinical summary on the management of fatigue in pwMS 
(Khan et  al.). Treatment options include non-pharmacological 
interventions such as multi-disciplinary rehabilitation, specific 
rehabilitation interventions, and physical modalities such as 
exercise, aquatic therapy, Tai chi, cooling devices among oth-
ers. Behavioral and educational interventions are also assessed, 
including fatigue management programs, energy conservation 
programs, mindfulness-based interventions, and cognitive and 
psychological interventions. Pharmacological interventions are 
reviewed as well and the evidence levels are summarized.
This Research Topic represents the first attempt to provide 
novel and the most up-to-date clinical, psychological, and physi-
ological data related to fatigue. It is a “must” for every clinician, 
neurologist, and psychologist dealing with pwMS and/or fatigue.
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